MST1 Suppression Reduces Early Brain Injury by Inhibiting the NF-κB/MMP-9 Pathway after Subarachnoid Hemorrhage in Mice
Open Access
- 19 June 2018
- journal article
- research article
- Published by Wiley in Behavioural Neurology
- Vol. 2018, 1-13
Abstract
Background. Mammalian sterile 20-like kinase 1 (MST1), the key component of the Hippo-YAP pathway, exhibits an important role in the pathophysiological process of various neurological disorders, including ischemic stroke and spinal cord injury. However, during subarachnoid hemorrhage, the involvement of MST1 in the pathophysiology of early brain injury remains unknown. Methods. We employed intravascular filament perforation to establish the subarachnoid hemorrhage (SAH) mouse model. The MST1 inhibitor XMU-MP-1 was intraperitoneally injected at 1 h after SAH, followed by daily injections. MST1 in vivo knockdown was performed 3 weeks prior to SAH via intracerebroventricular injection of adeno-associated virus (AAV) packaged with MST1 shRNA. The SAH grade, behavioral deficits, TUNEL staining, Evans blue dye extravasation and fluorescence, brain water content, protein and cytokine expressions by Western blotting, immunofluorescence, and proteome cytokine array were evaluated. Results. Following SAH, the phosphorylation level of MST1 was upregulated at 12 h, with a peak at 72 h after SAH. It was colocalized with the microglial marker Iba1. Both XMU-MP-1 and MST1 shRNA alleviated the neurological deficits, blood-brain barrier (BBB) disruption, brain edema, neuroinflammation, and white matter injury, which were induced by SAH in association with nuclear factor- (NF-) κB p65 and matrix metallopeptidase-9 (MMP-9) activation and downregulated endothelial junction protein expression. Conclusions. The current findings indicate that MST1 participates in SAH-induced BBB disruption and white matter fiber damage via the downstream NF-κB-MMP-9 signaling pathway. Therefore, MST1 antagonists may serve as a novel therapeutic target to prevent early brain injury in SAH patients.Keywords
Funding Information
- National Natural Science Foundation of China (81501002, 81220108009, WSS-2015-08, SWH2016ZDCX1011)
- National Natural Science Foundation of China (81501002, 81220108009, WSS-2015-08, SWH2016ZDCX1011)
- Interdisciplinary Laboratory of Physics and Biomedicine (81501002, 81220108009, WSS-2015-08, SWH2016ZDCX1011)
- Major Innovation Project of Southwest Hospital (81501002, 81220108009, WSS-2015-08, SWH2016ZDCX1011)
This publication has 29 references indexed in Scilit:
- Cyclosporine A alleviated matrix metalloproteinase 9 associated blood-brain barrier disruption after subarachnoid hemorrhage in miceNeuroscience Letters, 2017
- Deletion of mammalian sterile 20-like kinase 1 attenuates neuronal loss and improves locomotor function in a mouse model of spinal cord traumaMolecular and Cellular Biochemistry, 2017
- MST1/MST2 Protein Kinases: Regulation and Physiologic RolesBiochemistry, 2016
- Tanshinol suppresses inflammatory factors in a rat model of vascular dementia and protects LPS-treated neurons via the MST1-FOXO3 signaling pathwayBrain Research, 2016
- Hippo/MST1 signaling mediates microglial activation following acute cerebral ischemia–reperfusion injuryBrain, Behavior, and Immunity, 2016
- H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 HeterodimerizationCurrent Biology, 2016
- Controversies and evolving new mechanisms in subarachnoid hemorrhageProgress in Neurobiology, 2014
- The role of reciprocal activation of cAbl and Mst1 in the Oxidative death of cultured astrocytesGlia, 2014
- Early Brain Injury, an Evolving Frontier in Subarachnoid Hemorrhage ResearchTranslational Stroke Research, 2013
- Daxx mediates activation‐induced cell death in microglia by triggering MST1 signallingThe EMBO Journal, 2011